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Edited by Horst FeldmannAbstract Liposomes have long been used as possible compart-
ments for artiﬁcial cells, and it has been shown that liposomes
can sustain various types of biochemical reactions. To elevate the
degree of molecular complexity of the system in liposomes, we
have constructed a two-stage genetic network encapsulated in
liposomes. This two-stage genetic network was constructed with
the plasmid pTH, in which the protein product of the ﬁrst stage
(T7 RNA polymerase) is required to drive the protein synthesis
of the second stage (GFP). We show that the two-stage genetic
network constructed in a cell-free expression system is functional
within liposomes.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Challenges for synthesizing a minimal cell are expected to
provide clues for comprehending the essence of life and its
origin [1]. As an experimental approach to the minimal cell,
liposomes have long been used as a boundary for compart-
mentation [1–12], which is crucial to bring forth life and its
evolution [1,13]. Various types of biochemical reactions have
already been carried out within liposomes [2–11] and one of
the most essential of these reactions in living organisms is
RNA synthesis. Walde et al. [5] reported the enzymatic poly-
merization of ADP to poly(A) in vesicles using polynucleotide
phosphorylase. As this work developed further, replication of
a RNA template by Qb replicase [6] and mRNA synthesis
using a DNA template and T7 RNA polymerase [10] were
carried out in vesicles.
Another important reaction is protein synthesis, a more
complex reaction catalyzed by ribosomes. Oberholzer et al.
reported the ribosomal synthesis of poly(Phe) in liposomes
using poly(U) as the RNA messenger. By combining mRNA
synthesis and protein synthesis, we can construct a gene-* Corresponding author. Address: Department of Biotechnology,
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doi:10.1016/j.febslet.2004.09.046expression system. Furthermore, Yu et al. [9] demonstrated
that a GFP (green ﬂuorescent protein) can be synthesized in
liposomes by a coupled cell-free transcription and translation
system and that the synthesized protein is ﬂuorescent and
hence functional. Another GFP was also synthesized by a
similar coupled transcription and translation system in giant
vesicles [11].
The next step toward a higher degree of genetic complexity is
to construct a functional cell-free genetic network [14] in
liposomes. Here, we engineered a transcriptional activation
cascade in which the protein product of the ﬁrst stage is the
input required to drive the second stage. We selected a T7
RNA polymerase gene for the ﬁrst stage and a GFP gene, in
which expression is controlled by a T7 promoter, for the sec-
ond stage. We demonstrated that the transcriptional activation
cascade constructed in a cell-free expression system is func-
tional within liposomes. This study, hence, provides another
step forward in overcoming many challenges in pursuance of
synthesizing a minimal cell.2. Materials and methods
2.1. Materials
Escherichia coli strains used were BL21(DE3) (Novagen), JM109
[16], and DPB267 [17]. The E. coli DPB267 was a kind gift from Dr.
S.N. Cohen of Stanford Medical School. Plasmids used were pQE-30
(QIAGEN), pET21-GFPmut1-His6 [9], pQE-T7RNAP, pTH, and
pTHDT7RNAP. The plasmid pET21-GFPmut1-His6 contains a gene
for GFPmut1 with a C-terminal His-tag under the control of T7
promoter and was constructed as described previously [9]. The plas-
mids pQE-T7RNAP, pTH, and pTHDT7RNAP were prepared as
described below. T7 RNA polymerase and SP6 RNA polymerase were
purchased from TAKARA BIO INC., RNase was from Sigma, and
cholesterol was from Nacarai Tesque INC. EggPC (egg yolk phos-
phatidyl choline) and DSPE-PEG5000 (distearoyl phosphatidyl etha-
nolamine-poly(ethylene glycol) 5000) were kindly supplied by NOF
CORPORATION (Tokyo), and S-30 cell extract was prepared from
E. coli DPB267 as described by Zubay [18,19].
2.2. Construction of plasmids
Cloning was performed by following routine procedures [20]. The T7
RNA polymerase gene was obtained from the E. coli BL21(DE3) ge-
nome by PCR (polymerase chain reaction) using the forward primer
AGGCACGGATCCAACACGATTAACATCGCTAAG (underlined
bases indicate the BamHI site) and the reverse primer TGAT-
TTAAGCTTACGCGAACGCGAAGTCCGACTC (underlined bases
indicate the HindIII site). The ampliﬁed gene was inserted into the
BamHI and HindIII sites of plasmid pQE30 to produce the plasmid
pQE-T7RNAP. The cloned T7 RNA polymerase gene on theblished by Elsevier B.V. All rights reserved.
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GGGGGGAGATCTATTTAGGTGACACTATAGAATTGTGAGC-
GGATAACAATTTC (underlined bases indicate the BglII site and
bold bases the SP6 promoter) and the reverse primer CCCCCC-
AGATCTGCTAGCTTGGATTCTCACCAATAAAAAAC (under-
lined bases indicate the BglII site). The PCR product was inserted into
the BglII site of plasmid pET21-GFPmut1-His6 to produce the plas-
mid pTH (Fig. 1A). Plasmid pTHDT7RNAP, shown in Fig. 1B, was
prepared by digesting pTH with Eco81I and then self-ligating the
resulting fragments, deleting an approximately 180-bp fragment from
the T7 RNA polymerase gene.
2.3. Liposome preparation
The lipid mixture (1.2 lmol; molar ratio of eggPC:cholester-
ol:DSPE-PEG5000¼ 1.5:1:0.08) dissolved in dichloromethane/diethyl
ether (1:1, v/v) was rotary-evaporated in a pear-shaped ﬂask under
vacuum at room temperature to yield a thin lipid ﬁlm. Added to the
lipid ﬁlm was 100 ll of deionized water at room temperature. After
standing for 15 min at room temperature, the lipid ﬁlm was vortexed to
disperse the liposomes, with a ﬁnal concentration of 12 mM. The li-
posome dispersion sonicated with an ultrasonic disrupter (TOMY
SEIKO Co, Ltd.) was ﬁltered with a 0.4-lm polycarbonate ﬁlter
(Whatman Inc.). The solution was transferred into an Eppendorf tube
and lyophilized (Labconco Corporation). The reaction mixture (10 ll)
was added to yield the liposome dispersion as described below.
2.4. Coupled transcription and translation
The reaction conditions were almost the same as those described
previously [9]. The reaction mixture (40 ll) contained 88 mM Tris–
OAc (pH 8.2), 30 mM NH4OAc, 90 mM KOAc, 17 mM Mg(OAc)2,
2.5% PEG8000, 7.9 mM ATP, 0.88 mM each of GTP, UTP, and CTP,
0.325 mM each of the 20 types of amino acids, 1.75 mM dithiothreitol,
0.5 mM IPTG (isopropylthiogalactoside), 128 lg/ml folic acid, 0.17
mg/ml tRNA, 28.2 mM phosphoenol pyruvate, 0.65 mM cAMP,
16 nM of template DNA, and 8.0 ll of E. coli S-30 cell extract. When
reactions were carried out in liposomes, 10 ll of the reaction mixture
was added to the lyophilized liposomes described above and mixed by
pipetting at 4 C to disperse the liposomes to give a ﬁnal lipid con-
centration of 120 mM. The liposome dispersion kept at 4 C was di-
luted with 70 ll of the cold reaction mixture, which is the same as that
entrapped inside the liposomes except that it contains 12 lg/ml RNaseFig. 1. Structures of plasmids pTH (A) and pTHDT7RNAP (B). The
abbreviation Ampr represents the ampicillin-resistance-coding region.and no template DNA. The RNase concentration used was conﬁrmed
to ensure that protein synthesis would not occur outside the liposomes.
To initiate protein expression, the reaction mixture or diluted liposome
dispersion prepared as described above was kept at 4 C and incubated
at 37 C.
2.5. SDS–PAGE analysis of proteins produced by coupled
transcription-translation
Proteins were synthesized in the cell-free expression system (40 ll) as
described above, with the addition of 1.1 mCi/ll L-[35S] Methionine
(Amersham Pharmacia Biotech). After 1-h incubation at 37 C, the
solution was added to 320 ll of ice-cold acetone and kept on ice for 15
min to precipitate the translation products. The precipitate was col-
lected by centrifugation, dried under vacuum at room temperature,
and analyzed by SDS–PAGE using a 12% gel. Following electropho-
resis, the gel was soaked in a ﬁxing buﬀer (isopropanol:acetic acid:-
water¼ 5:2:13, v/v) for 30 min and then in Amplify (Amersham
Bioscience K.K.) for 30 min. After drying by heating under vacuum,
the gel was exposed to Hyperﬁlm MP (Amersham Pharmacia Bio-
tech) at )70 C for 8 h. The ﬁlm was developed with a ﬁlm processor
(FPM100, Fuji Medical Systems Ltd., Tokyo, Japan).
2.6. Flow cytometric analysis of protein synthesis in liposomes
Liposomes encapsulating the cell-free expression system were pre-
pared at 4 C as described above. The liposome dispersion was incu-
bated at 37 C for 1 h, after which the reaction was terminated by
immediately placing the tube on ice. The production of GFPmut1-His6
in liposomes was analyzed with an EPICS ALTRA HyPerSort ﬂow
cytometer (Beckman Coulter, Miami, FL, USA) equipped with a
488-nm water-cooled argon ion laser (Coherent Japan, Inc.) at 20 mW.
The analytical conditions were almost the same as those described
previously [9]. The Flow-check Fluorospheres 10-lm bead (Beckman
Coulter, Inc.) was introduced prior to measuring samples for align-
ment of the 488-nm argon ion laser source to set half-peak coeﬃcients
of variation (CVs) to less than 1.5%. In order to calibrate the daily
variance, ﬂuorescence-labeled latex beads of 0.5, 1, 2, 3, and 6 lm
(ﬂuorescent ﬂow cytometer calibration grade-size range kit, Poly-
science Inc., Warrington, PA, USA) were used. A discriminator of 60
channels out of 1024 was set on forward scatter (FS). Fluorescence
signals were then measured successively using a 488-nm band block
ﬁlter, a 550-nm dichroic lens, and a bandpass ﬁlter at 525 10 nm.
Fluorescence intensity and FS data were collected with a logarithmic
ampliﬁer, and GFPmut1-His6 synthesis in 2.5 105 liposomes of each
sample was analyzed.3. Results and discussion
A two-stage cascading genetic network was constructed with
the plasmid pTH, which contains the T7 RNA polymerase
gene under the control of the SP6 promoter and the GFPmut1-
His6 gene under the T7 promoter (Fig. 1A). The cascading
network was designed to work in a manner that the SP6 RNA
polymerase input drives the production of T7 RNA polymer-
ase, which in turn induces the expression of GFPmut1-His6.
GFPmut1 is a mutant of GFP exhibiting ﬂuorescence 35 times
as intense as that of the wild type [15]. The cascading network
was characterized in a test tube using an E. coli cell-free ex-
pression system described in Section 2. SDS–PAGE (sodium
dodecyl sulfate-polyacrylamide gel electrophoresis) analysis of
the proteins labeled by the incorporation of [35S]Met during
the cell-free protein synthesis revealed that both GFPmut1-
His6, with an expected molecular weight of about 28 kDa, and
T7 RNA polymerase, with an expected molecular weight of
about 100 kDa, were produced irrespective of whether SP6
RNA polymerase was added (Fig. 2, lanes 4 and 6). The un-
expected expression of the T7 RNA polymerase gene without
the addition of SP6 RNA polymerase may be due to the
possibilities that RNA polymerase in the E. coli S-30 cell
extract recognizes the SP6 promoter and/or unknown pro-
Fig. 2. Expression of RNA polymerases and GFPmut1-His6. Proteins
synthesized in the cell-free expression system containing [35S]Met were
analyzed by SDS–PAGE and visualized by autoradiography, as de-
scribed in Section 2. The template DNAs used were: pET21-GFPmut1-
His6 for lanes 1–3; pTH for lanes 4–6; and pTHDT7RNAP for lanes 7–9.
To the reaction mixtures for lanes 2, 5, and 8, T7 RNA polymerase was
added (0.5 Units/ll), to those for lanes 3, 6, and 9, SP6RNApolymerase
was added (0.5 Units/ll), and to those for lanes 1, 4, and 7, no RNA
polymerase was added. Lane M: marker proteins (Rainbow
[14C]methylated protein molecular-weight markers, 148 kBq/ml).
Fig. 3. Kinetics of GEPmut1-His6 production in cell-free expression
system. Time courses of GFPmut1-His6 expression in the coupled
transcription-translation system described in Section 2 were monitored
at 37 C by the increase in the ﬂuorescence emission at 545 nm (exci-
tation at 488 nm) of the reaction mixture using an ABI PRISM 7700
Sequence Detector (PE Applied Biosystems). The template DNAs used
were pTH (ﬁlled circle) and pTHDT7RNAP (ﬁlled square, ﬁlled tri-
angle). To the reaction mixture for a ﬁlled square, T7 RNA polymerase
was added.
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gene, although the activity of the SP6 promoter for E. coli
RNA polymerase was reported to be very weak [21]. However,
the unexpected expression of the T7 RNA polymerase gene
does not alter the essential system of the two-stage genetic
network constructed with the plasmid pTH; it only simpliﬁes
the system by omitting the addition of the SP6 RNA
polymerase.
To conﬁrm that the expression of the T7 RNA polymerase
gene on the plasmid pTH is necessary to express the GFP gene
on the same plasmid, the same experiment was conducted re-
placing pTH with pTHDT7RNAP, which contains the gene for
an inactive deletion mutant of T7 RNA polymerase instead of
the wild-type polymerase gene of pTH (Fig. 1B). The results
revealed that while the deleted mutant, with an expected
molecular weight of about 94 kDa, was produced regardless of
the addition of SP6 RNA polymerase (Fig. 2, lanes 7
and 9), GFPmut1-His6 was produced from the plasmid
pTHDT7RNAP only by adding T7 RNA polymerase exoge-
nously (Fig. 2, lanes 7 and 8). The above results indicate that
the T7 RNA polymerase gene on the plasmid pTH is expressed
without the addition of SP6 RNA polymerase in the cell-free
expression system, and that active T7 RNA polymerase is re-
quired for the expression of the GFP gene on the plasmid. In
these experiments, it was found that the exogenous T7 RNA
polymerase depressed the expression of the wild type or the
mutant T7 RNA polymerase gene (Fig. 2 lanes 5 and 8). Such
a result indicates that competition may exist between the ex-
pressions of T7 RNA polymerase (or its mutant) and GFP-
mut1-His6 genes on the same plasmid at the transcriptional
and/or translational levels. Based on the results so far de-
scribed, we concluded that the two-stage genetic network using
pTH operates as a transcriptional activation cascade in the
cell-free expression system without the addition of SP6 RNA
polymerase.
The kinetics of the production of GFPmut1-His6 in the
cell-free expression system was monitored by the increase in
the ﬂuorescence (Fig. 3). In comparison to the production
of GFPmut1-His6 by the single-stage system using
pTHDT7RNAP and added T7 RNA polymerase, a delay of
about 20 min was observed for the production by the two-stage cascading network using pTH, where T7 RNA poly-
merase is newly synthesized in the expression system (Fig. 3).
This delay seems to be the time needed to accumulate T7 RNA
polymerase, which transcribes the GFP gene, and hence, is a
characteristic property of a network working as an activation
cascade [14].
The reaction mixture for the cell-free production of GFP-
mut1-His6 by the two-stage cascading genetic network de-
scribed above was encapsulated in liposomes at 4 C. After
encapsulation, RNase was added to inhibit protein synthesis
outside the liposomes resulting from any non-entrapped re-
action components. The reaction was then initiated by ele-
vating the temperature to 37 C. After 1 h, the liposomes were
examined by ﬂow cytometry (Fig. 4), with the basal back-
ground being determined by running samples in which lipo-
somes were dispersed by the reaction mixture without the
plasmid DNA (Fig. 4B). A dot with ﬂuorescence detected
beyond the basal background indicates the liposome in which
functional GFPmut1-His6 was synthesized. As Fig. 4A shows,
it is evident that functional GFP was synthesized within the
liposomes encapsulating the reaction mixture for the expres-
sion of the two-stage cascading genetic network, as indicated
by the signiﬁcant amount of liposomes ﬂuorescing above the
background level. When 12 lg/ml RNase was included both in
the reaction mixture entrapped inside the liposome and in the
solution outside the liposome, the result shown in Fig. 4C
occurred, which was almost the same as that for the basal
background (Fig. 4B). Such a result indicates that the presence
of RNase inhibits the GFP synthesis almost completely.
Therefore, the addition of RNase after the reaction mixture
was encapsulated in the liposomes ascertained that the ﬂuo-
rescence detected above the background level could be at-
tributed mostly to GFPmut1-His6 synthesized inside the
liposome and not that outside it.
In our previous work, we demonstrated the synthesis of a
functional protein, the ﬂuorescent GFPmut1-His6, within
liposomes [9]. The present results elevate the degree of
Fig. 4. Flow cytometric analysis of GFPmut1-His6 production by the two-stage cascading network in liposomes. Liposomes encapsulating the cell-
free expression system with (A, C) or without (B) the pTH template DNA were analyzed with a ﬂow cytometer after incubation at 37 C for 1 h, as
described in Section 2. (A, B) 12 lg/ml RNase was included in the solution outside the liposome. (C) 12 lg/ml RNase was included both in the
solution inside the liposome and outside the liposome. Each dot represents one liposome.
390 K. Ishikawa et al. / FEBS Letters 576 (2004) 387–390molecular complexity of the system to a level showing that the
two-stage genetic network encapsulated in liposomes is func-
tional and works as a transcriptional activation cascade. Al-
though there is still room for improvement to the system, and
quantitative analysis is needed for further characterization of
it, the fact that a functional genetic network, which is a simple
element of a much more complex network in a living cell, can
be constructed within liposomes is an important step forward
to overcoming many challenges in pursuance of synthesizing a
minimal cell.
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